Oric Pharmaceuticals IncNASDAQ:ORIC
- LAST PRICE11.2500
- TODAY'S CHANGE (%)0.0900 (0.8065%)
- Bid / Lots10.2000/ 1
- Ask / Lots11.5000/ 5
- Open / Previous Close11.1600 / 11.1600
- Day Range
- 52 Week Range
- Volume1,743,996
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORIC |
|---|---|---|
| 09:32 ET | 125880 | 11.07 |
| 09:34 ET | 6632 | 11.2 |
| 09:36 ET | 200 | 11.2 |
| 09:38 ET | 500 | 11.315 |
| 09:39 ET | 8788 | 11.305 |
| 09:41 ET | 6516 | 11.36 |
| 09:43 ET | 6013 | 11.255 |
| 09:45 ET | 8690 | 11 |
| 09:48 ET | 944 | 11.065 |
| 09:50 ET | 5518 | 11.05 |
| 09:52 ET | 14426 | 10.96 |
| 09:54 ET | 800 | 11.01 |
| 09:56 ET | 200 | 10.96 |
| 09:57 ET | 400 | 10.94 |
| 10:01 ET | 1496 | 10.915 |
| 10:06 ET | 14326 | 10.82 |
| 10:08 ET | 1493 | 10.82 |
| 10:10 ET | 2056 | 10.89 |
| 10:14 ET | 500 | 10.87 |
| 10:15 ET | 7915 | 10.83 |
| 10:17 ET | 900 | 10.92 |
| 10:19 ET | 3130 | 10.9 |
| 10:21 ET | 500 | 10.935 |
| 10:26 ET | 1300 | 10.965 |
| 10:28 ET | 200 | 10.965 |
| 10:30 ET | 4643 | 11.065 |
| 10:32 ET | 818 | 11.12 |
| 10:33 ET | 785 | 11.068 |
| 10:35 ET | 800 | 11.14 |
| 10:39 ET | 400 | 11.1625 |
| 10:42 ET | 176 | 11.16 |
| 10:44 ET | 100 | 11.165 |
| 10:48 ET | 766 | 11.175 |
| 10:50 ET | 100 | 11.18 |
| 10:51 ET | 500 | 11.17 |
| 10:53 ET | 200 | 11.17 |
| 10:55 ET | 889 | 11.16 |
| 10:57 ET | 1100 | 11.22 |
| 11:00 ET | 491 | 11.22 |
| 11:02 ET | 2742 | 11.18 |
| 11:06 ET | 200 | 11.195 |
| 11:08 ET | 686 | 11.23 |
| 11:09 ET | 200 | 11.25 |
| 11:11 ET | 1500 | 11.25 |
| 11:13 ET | 3232 | 11.31 |
| 11:15 ET | 102 | 11.32 |
| 11:18 ET | 1726 | 11.28 |
| 11:20 ET | 2741 | 11.33 |
| 11:24 ET | 3464 | 11.4059 |
| 11:26 ET | 731 | 11.35 |
| 11:31 ET | 300 | 11.36 |
| 11:33 ET | 1700 | 11.23 |
| 11:36 ET | 1715 | 11.21 |
| 11:38 ET | 346 | 11.29 |
| 11:40 ET | 246 | 11.31 |
| 11:42 ET | 324 | 11.31 |
| 11:44 ET | 700 | 11.37 |
| 11:45 ET | 1765 | 11.38 |
| 11:47 ET | 100 | 11.36 |
| 11:49 ET | 1585 | 11.365 |
| 11:51 ET | 100 | 11.36 |
| 11:54 ET | 2050 | 11.31 |
| 11:56 ET | 478 | 11.35 |
| 11:58 ET | 1660 | 11.37 |
| 12:03 ET | 100 | 11.34 |
| 12:05 ET | 3027 | 11.24 |
| 12:07 ET | 200 | 11.21 |
| 12:09 ET | 1045 | 11.22 |
| 12:14 ET | 500 | 11.19 |
| 12:18 ET | 100 | 11.185 |
| 12:20 ET | 400 | 11.195 |
| 12:21 ET | 200 | 11.17 |
| 12:23 ET | 1211 | 11.25 |
| 12:25 ET | 513 | 11.26 |
| 12:27 ET | 425 | 11.3 |
| 12:32 ET | 1850 | 11.26 |
| 12:34 ET | 700 | 11.22 |
| 12:38 ET | 600 | 11.18 |
| 12:39 ET | 100 | 11.17 |
| 12:41 ET | 929 | 11.17 |
| 12:45 ET | 2187 | 11.185 |
| 12:48 ET | 920 | 11.25 |
| 12:50 ET | 400 | 11.2275 |
| 12:52 ET | 5716 | 11.25 |
| 12:54 ET | 100 | 11.25 |
| 12:56 ET | 100 | 11.25 |
| 12:57 ET | 500 | 11.25 |
| 12:59 ET | 300 | 11.25 |
| 01:01 ET | 500 | 11.25 |
| 01:03 ET | 450 | 11.25 |
| 01:06 ET | 100 | 11.25 |
| 01:08 ET | 200 | 11.25 |
| 01:10 ET | 1400 | 11.3 |
| 01:14 ET | 2112 | 11.35 |
| 01:15 ET | 200 | 11.4 |
| 01:17 ET | 1835 | 11.39 |
| 01:19 ET | 821 | 11.36 |
| 01:21 ET | 1382 | 11.405 |
| 01:24 ET | 1456 | 11.37 |
| 01:26 ET | 433 | 11.39 |
| 01:28 ET | 577 | 11.38 |
| 01:30 ET | 725 | 11.37 |
| 01:32 ET | 900 | 11.34 |
| 01:33 ET | 457 | 11.32 |
| 01:35 ET | 500 | 11.355 |
| 01:37 ET | 1052 | 11.36 |
| 01:39 ET | 300 | 11.42 |
| 01:42 ET | 1268 | 11.41 |
| 01:44 ET | 700 | 11.43 |
| 01:46 ET | 290 | 11.44 |
| 01:48 ET | 1637 | 11.405 |
| 01:50 ET | 400 | 11.41 |
| 01:51 ET | 400 | 11.41 |
| 01:53 ET | 1127 | 11.41 |
| 01:55 ET | 556 | 11.395 |
| 01:57 ET | 200 | 11.4 |
| 02:00 ET | 300 | 11.39 |
| 02:02 ET | 525 | 11.39 |
| 02:04 ET | 300 | 11.39 |
| 02:06 ET | 1000 | 11.38 |
| 02:08 ET | 300 | 11.4 |
| 02:09 ET | 300 | 11.4 |
| 02:11 ET | 3185 | 11.38 |
| 02:13 ET | 850 | 11.42 |
| 02:15 ET | 400 | 11.47 |
| 02:18 ET | 603 | 11.47 |
| 02:20 ET | 200 | 11.48 |
| 02:22 ET | 1547 | 11.47 |
| 02:24 ET | 300 | 11.48 |
| 02:26 ET | 1600 | 11.46 |
| 02:27 ET | 300 | 11.48 |
| 02:29 ET | 900 | 11.47 |
| 02:31 ET | 719 | 11.46 |
| 02:33 ET | 200 | 11.44 |
| 02:36 ET | 900 | 11.43 |
| 02:38 ET | 300 | 11.44 |
| 02:40 ET | 1897 | 11.44 |
| 02:42 ET | 1564 | 11.445 |
| 02:44 ET | 16315 | 11.485 |
| 02:45 ET | 2683 | 11.49 |
| 02:47 ET | 800 | 11.485 |
| 02:49 ET | 53530 | 11.6509 |
| 02:51 ET | 1832 | 11.66 |
| 02:54 ET | 650 | 11.66 |
| 02:56 ET | 300 | 11.66 |
| 02:58 ET | 2857 | 11.62 |
| 03:00 ET | 650 | 11.59 |
| 03:02 ET | 2135 | 11.46 |
| 03:03 ET | 1599 | 11.55 |
| 03:05 ET | 969 | 11.57 |
| 03:07 ET | 1100 | 11.5432 |
| 03:09 ET | 1572 | 11.535 |
| 03:12 ET | 700 | 11.57 |
| 03:14 ET | 1715 | 11.55 |
| 03:16 ET | 1550 | 11.54 |
| 03:18 ET | 1199 | 11.51 |
| 03:20 ET | 200 | 11.53 |
| 03:21 ET | 1000 | 11.52 |
| 03:23 ET | 2221 | 11.56 |
| 03:25 ET | 200 | 11.54 |
| 03:30 ET | 2394 | 11.61 |
| 03:32 ET | 997 | 11.58 |
| 03:34 ET | 3156 | 11.6 |
| 03:36 ET | 100 | 11.6 |
| 03:38 ET | 103 | 11.61 |
| 03:39 ET | 6336 | 11.55 |
| 03:41 ET | 1996 | 11.4668 |
| 03:43 ET | 988 | 11.46 |
| 03:45 ET | 2153 | 11.44 |
| 03:48 ET | 1894 | 11.42 |
| 03:50 ET | 1933 | 11.4 |
| 03:52 ET | 28027 | 11.27 |
| 03:54 ET | 6543 | 11.38 |
| 03:56 ET | 13154 | 11.275 |
| 03:57 ET | 5473 | 11.28 |
| 03:59 ET | 775315 | 11.25 |
Sep 18, 2024
DJ Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 1:42PM ET on Wednesday Sep 18, 2024 by Dow Jones
1:42PM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 10, 2024
DJ Oric Pharmaceuticals Price Target Maintained With a $20.00/Share by Wedbush, from 9:08AM ET on Tuesday Sep 10, 2024 by Dow Jones
9:08AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 6, 2024
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Sep 06, 2024 by Dow Jones
4:30PM ET on Friday Sep 06, 2024 by Dow JonesDJ Oric Pharmaceuticals Initiated at Buy by Stifel, from 11:39AM ET on Friday Sep 06, 2024 by Dow Jones
11:39AM ET on Friday Sep 06, 2024 by Dow Jones
Aug 26, 2024
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences, from 4:05PM ET on Monday Aug 26, 2024 by Dow Jones
4:05PM ET on Monday Aug 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oric Pharmaceuticals Inc | 787.3M | -6.4x | --- |
Olema Pharmaceuticals Inc | 778.8M | -6.6x | --- |
Replimune Group Inc | 767.2M | -3.3x | --- |
Savara Inc | 763.7M | -10.4x | --- |
Arrivent Biopharma Inc | 812.8M | -10.1x | --- |
Annexon Inc | 742.2M | -5.8x | --- |
Company Information
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Contact Information
- Headquarters
- 240 E. Grand Ave, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-388-5600
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Heyman
- President, Chief Executive Officer, Director
- Jacob Chacko
- Chief Financial Officer
- Dominic Piscitelli
- Chief Medical Officer
- Pratik Multani
- Independent Director
- Mardi Dier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $787.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.11 |
EPS | $-1.76 |
Book Value | $4.08 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
